Literature DB >> 15070600

Heat shock protein 70 is induced in mouse human colon tumor xenografts after sublethal radiofrequency ablation.

Weng-Lang Yang1, Deepak G Nair, Ryouji Makizumi, George Gallos, Xuemei Ye, Rohit R Sharma, T S Ravikumar.   

Abstract

BACKGROUND: Radiofrequency ablation (RFA) destroys tumor cells by generating high temperatures through ionic vibration. Tumor recurrence may be a direct function of sublethal temperature. Further, a set of proteins called heat shock proteins (HSPs) can be synthesized under heat stress to facilitate recovery of tumor cells from heat damage.
METHODS: Subcutaneous xenografts were induced in nude mice by injection with HT29 human colon cancer cells. The tumors were exposed surgically and subjected to RFA. The tumors were randomly assigned to achieve a target tumor temperature of 42 degrees C, 45 degrees C, or 50 degrees C. Total RNA and cell lysates were isolated from tumor tissues and subjected to reverse transcription-polymerase chain reaction and Western blot analyses, respectively, at various time points after treatments for assessing HSP expression. For in vitro experiments, HT29 cells were subjected to variable temperatures, and HSP expression was assayed.
RESULTS: During a 50-day follow-up, the recurrence rates were 0% at 50 degrees C, 30% at 45 degrees C, and 100% at 42 degrees C. The messenger RNA and protein levels of HSP90 and HSP27 remained unchanged after RFA at 45 degrees C; however, HSP70 was induced at 4 and 10 hours after RFA. In vitro HT29 culture cells subjected to a heated water bath exhibited a cellular sensitivity to heat and change of HSP expression similar to those in tumor xenografts subjected to RFA.
CONCLUSIONS: Our data establish the requisite heat parameters during RFA for human colon tumors in vitro and in vivo. Because HSP70 plays an important role in protecting cell death from a variety of stresses, HSP70 could be a potential target for enhancing the efficacy of RFA.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15070600     DOI: 10.1245/ASO.2004.08.013

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  21 in total

1.  Development of a highly efficient implanted thermal ablation device: in vivo experiment in rat liver.

Authors:  H Matsui; M Hamuro; K Nakamura; H Kayahara; K Murano; Y Kotsuka; Y Miki
Journal:  Br J Radiol       Date:  2012-03-14       Impact factor: 3.039

Review 2.  InCVAX--a novel strategy for treatment of late-stage, metastatic cancers through photoimmunotherapy induced tumor-specific immunity.

Authors:  Feifan Zhou; Xiaosong Li; Mark F Naylor; Tomas Hode; Robert E Nordquist; Luciano Alleruzzo; Joseph Raker; Samuel S K Lam; Nan Du; Lei Shi; Xiuli Wang; Wei R Chen
Journal:  Cancer Lett       Date:  2015-01-26       Impact factor: 8.679

Review 3.  Thermal ablation of tumours: biological mechanisms and advances in therapy.

Authors:  Katrina F Chu; Damian E Dupuy
Journal:  Nat Rev Cancer       Date:  2014-03       Impact factor: 60.716

4.  Elevated serum levels of heat shock protein 70 can be detected after radiofrequency ablation.

Authors:  Sebastian P Haen; Cécile Gouttefangeas; Diethard Schmidt; Andreas Boss; Stephan Clasen; Alexandra von Herbay; Bora Kosan; Hermann Aebert; Philippe L Pereira; Hans-Georg Rammensee
Journal:  Cell Stress Chaperones       Date:  2011-03-26       Impact factor: 3.667

5.  Pre-resectional Radiofrequency Ablation as a Neoadjuvant in situ Tumor Vaccine.

Authors:  Fumito Ito; Sharon S Evans
Journal:  J Vaccines Vaccin       Date:  2016-03-09

Review 6.  Postablation Immune Microenvironment: Synergy between Interventional Oncology and Immuno-oncology.

Authors:  DaeHee Kim; Joseph P Erinjeri
Journal:  Semin Intervent Radiol       Date:  2019-10-31       Impact factor: 1.513

7.  Combination radiofrequency (RF) ablation and IV liposomal heat shock protein suppression: reduced tumor growth and increased animal endpoint survival in a small animal tumor model.

Authors:  Wei Yang; Muneeb Ahmed; Beenish Tasawwar; Tatynana Levchenko; Rupa R Sawant; Vladimir Torchilin; S Nahum Goldberg
Journal:  J Control Release       Date:  2011-12-30       Impact factor: 9.776

8.  Radiofrequency ablation combined with liposomal quercetin to increase tumour destruction by modulation of heat shock protein production in a small animal model.

Authors:  Wei Yang; Muneeb Ahmed; Beenish Tasawwar; Tatyana Levchenko; Rupa R Sawant; Michael Collins; Sabina Signoretti; Vladimir Torchilin; S Nahum Goldberg
Journal:  Int J Hyperthermia       Date:  2011       Impact factor: 3.914

9.  Abrogation of local cancer recurrence after radiofrequency ablation by dendritic cell-based hyperthermic tumor vaccine.

Authors:  Qiong Liu; Bo Zhai; Wen Yang; Le-Xing Yu; Wei Dong; Ya-Qin He; Lei Chen; Liang Tang; Yan Lin; Dan-Dan Huang; Hong-Ping Wu; Meng-Chao Wu; He-Xin Yan; Hong-Yang Wang
Journal:  Mol Ther       Date:  2009-09-22       Impact factor: 11.454

10.  In situ thermal ablation augments antitumor efficacy of adoptive T cell therapy.

Authors:  Fumito Ito; Trupti D Vardam; Michelle M Appenheimer; Kevin H Eng; Sandra O Gollnick; Jason B Muhitch; Sharon S Evans
Journal:  Int J Hyperthermia       Date:  2019-11       Impact factor: 3.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.